TeraFlu Lar tablets for sucking, # 16

TeraFlu LAR tab No. 16

Name ENG

THERAFLU LAR

Clinical and pharmacological group

Drug with antimicrobial and local anesthetic action for local use in ENT practice and dentistry

ATX code

Drugs for the treatment of diseases of the pharynx

Dosage

1mg + 1mg

Structure

1 tablet contains: Active substances: benzoxonium chloride 1 mg, lidocaine hydrochloride 1 mg Excipients: sorbitol - 1 g (corresponds to approximately 17 kJ / 4 kcal), MCC, macrogol 6000, corn starch, sodium saccharin, sodium chloride, citric acid , magnesium stearate, orange flavor.

Indications

Infectious and inflammatory diseases of the oral cavity and pharynx:

pharyngitis

laryngitis

catarrhal sore throat

stomatitis

ulcerative gingivitis

chronic tonsillitis (as an aid).

Storage conditions and periods

In a dry place, at a temperature not exceeding 30 degrees.

Expiration date: 3 years

INN / Active ingredient

Benzoxonium chloride + lidocaine hydrochloride monohydrate

Contraindications

hypersensitivity to lidocaine or ammonia compounds

I trimester of pregnancy

lactation period (breastfeeding)

children's age (up to 4 years).

Specifications

Category

Sore throat

Scope of the medicinal product

Ear, Throat, Nose

Release form

Tablet

Manufacturer country

India

Package quantity, pcs

16

Scope of application

Otorhinolaryngology

Minimum age from

4 years old

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Teraflu

The amount of the dosage form in the primary package

8 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antiseptic

Anatomical and therapeutic characteristics

R02AA20 Other antiseptics

Dosage form

Lozenges

Dosage (volume) of the substance in the preparation

Benzoxonium chloride 1 mg, lidocaine hydrochloride 1 mg

Expiration date in days

1095

The target audience

Children

Package weight, g

thirty

Mode of application

:

TeraFlu LAR is used topically.

< br> Tablets: dissolve slowly in the mouth until completely dissolved.

< br> Adults - 1 table.

for resorption every 2-3 hours. With severe symptoms of the disease, it is possible to use 1 table.

every 1–2 hours. The daily dose should not exceed 10 tablets.

< br> Children aged 4 years and older - 1 table.

for resorption every 2-3 hours. The daily dose should not exceed 6 tablets.

< br> Duration of treatment - no more than 5 days.

< br> If relief of symptoms is not observed within 5 days of therapy, the patient should consult a doctor.